|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product | |||||
| License | |||||
| Royalty | |||||
| Total revenue | |||||
| Operating costs and expenses: | |||||
| Cost of sales | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| In-process research and development expenses | |||||
| Total operating costs and expenses | |||||
| Income from operations | |||||
| Other income (expenses): | |||||
| Interest income | |||||
| Loss on debt extinguishment | |||||
| Interest expense | |||||
| Legal verdict expense | |||||
| Other income | |||||
| Total other expenses, net | |||||
| Income Before Income Taxes | |||||
| Income tax expense | |||||
| Current income tax (expense) | |||||
| Deferred income tax (expense) benefit | |||||
| Total income tax expense | |||||
| Net income | |||||
| Net income per share of common stock—basic (in dollars per share) | |||||
| Net income per share of common stock—diluted (in dollars per share) | |||||
| Weighted-average shares of common stock outstanding—basic (in shares) | |||||
| Weighted-average shares of common stock outstanding—diluted (in shares) | |||||
Loading...